Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
GLOW is a triple-peptide blend containing BPC-157 (a 15-amino acid gastric peptide), TB-500 (a 43-amino acid thymosin beta-4 fragment), and GHK-Cu (a copper tripeptide)
Q&A 1.How could l get a sample
It is not a drug, food, cosmetic, or dietary supplement, has not been evaluated by the FDA
There are a few things you can do to manage high blood pressure during pregnancy without medication and during the perinatal period